Healthcare - Biotechnology - NASDAQ - US
$ 13.31
-7.05 %
$ 1.34 B
Market Cap
-13.72
P/E
CASH FLOW STATEMENT
-147 M
OPERATING CASH FLOW
128 M
INVESTING CASH FLOW
164 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Day One Biopharmaceuticals, Inc.
| Net Income | -189 M |
| Depreciation & Amortization | 383 K |
| Capital Expenditures | -3.22 M |
| Stock-Based Compensation | 39.3 M |
| Change in Working Capital | 9.42 M |
| Others | 24 K |
| Free Cash Flow | -150 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||
| Net Income | (188.9) | (142.2) | (72.8) | (43.8) | (17.0) |
| Depreciation & Amortization | 0.4 | 0.5 | 0.2 | 0.2 | 0 |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation | 39.3 | 27.2 | 13.3 | 0.5 | 0.1 |
| Other Operating Activities | (7.1) | (2.0) | 8.0 | 30.0 | 11.9 |
| Change in Working Capital | 9.4 | 6.6 | 2.7 | (0.4) | 0.4 |
| Cash From Operations | (146.9) | (109.9) | (48.5) | (13.5) | (4.5) |
| INVESTING CASH FLOW | |||||
| Capital Expenditures | (3.2) | 26 K | (8.0) | 92 K | 0 |
| Other Items | 131.6 | (255.0) | 0 | 0 | 0 |
| Cash From Investing Activities | 128.4 | (255.1) | (8.0) | 92 K | 0 |
| FINANCING CASH FLOW | |||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 0 | 1.0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 2.6 | 4.3 | 130.1 | 30.0 | 29.9 |
| Cash From Financing Activities | 164.0 | 165.9 | 297.1 | 30.0 | 30.9 |
| CHANGE IN CASH | |||||
| Net Change In Cash | 145.5 | (199.0) | 240.6 | 16.4 | 26.4 |
| FREE CASH FLOW | |||||
| Free Cash Flow | (150.1) | (109.9) | (56.5) | (13.6) | (4.5) |